Keisha C. McCall

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Preclinical xenograft models have contributed to advancing our understanding of the molecular basis of prostate cancer and to the development of targeted therapy. However, traditional preclinical in vivo techniques using caliper measurements and survival analysis evaluate the macroscopic tumor behavior, whereas tissue sampling disrupts the microenvironment(More)
  • 1